|
LOC100129550 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.611400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.414200E-01 |
| Normal-vs-Stage2 |
1.534220E-01 |
| Normal-vs-Stage3 |
1.194000E-01 |
| Normal-vs-Stage4 |
3.790300E-02 |
| Stage1-vs-Stage2 |
1.318360E-01 |
| Stage1-vs-Stage3 |
7.971900E-02 |
| Stage1-vs-Stage4 |
2.280200E-02 |
| Stage2-vs-Stage3 |
8.184600E-01 |
| Stage2-vs-Stage4 |
7.344000E-01 |
| Stage3-vs-Stage4 |
4.763800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.677210E-01 |
| Normal-vs-AfricanAmerican |
8.415200E-01 |
| Normal-vs-Asian |
1.499970E-01 |
| Caucasian-vs-AfricanAmerican |
1.429960E-01 |
| Caucasian-vs-Asian |
6.555600E-02 |
| AfricanAmerican-vs-Asian |
2.497800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.339600E-01 |
| Normal-vs-Female |
3.979200E-01 |
| Male-vs-Female |
5.823600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.075400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.312200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.191410E-01 |
| Normal-vs-Age(81-100Yrs) |
9.941000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.219600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.834800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.630100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.917600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.840310E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.013950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.378400E-01 |
| Normal-vs-Grade 2 |
8.337400E-01 |
| Normal-vs-Grade 3 |
1.181780E-01 |
| Normal-vs-Grade 4 |
1.333900E-02 |
| Grade 1-vs-Grade 2 |
3.492600E-01 |
| Grade 1-vs-Grade 3 |
7.870200E-02 |
| Grade 1-vs-Grade 4 |
1.288340E-02 |
| Grade 2-vs-Grade 3 |
8.412300E-02 |
| Grade 2-vs-Grade 4 |
6.844100E-03 |
| Grade 3-vs-Grade 4 |
1.918950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.985050E-01 |
| Normal-vs-ccB subtype |
9.557000E-01 |
| ccA subtype-vs-ccB subtype |
1.291400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.183600E-01 |
| Normal-vs-N1 |
6.048200E-01 |
| N0-vs-N1 |
4.184200E-01 |
|
|
